Haleon plc Board Committee Changes

SEC Filing 6-K (0001654954-25-008636)

Haleon plc (LSE/NYSE: HLN) announced changes to its board committees on 30 July 2025. Bláthnaid Bergin was appointed to the Audit & Risk Committee, and Matt Shattock was appointed to the Environmental & Social Sustainability Committee, both effective from 30 July 2025. This notification was made in accordance with Listing Rule 6.4.6R of the UK Listing Rules. Haleon plc is a global leader in consumer health, with a portfolio that includes well-known brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren. The company aims to deliver better everyday health with humanity.